Creatine for Women in Perimenopause: What the Evidence Actually Shows
Creatine is the most-discussed supplement in perimenopause right now. The research is genuinely encouraging in one specific area — and considerably weaker in the ones being marketed hardest.
Creatine has moved, in about two years, from a bodybuilding supplement to something recommended to nearly every woman over forty. Patients ask me about it almost weekly now, usually after seeing it described as protective for bone, muscle, mood, and memory all at once.
The research is real, and some of it is genuinely encouraging. It also does not say what the louder versions of this conversation suggest it says. Here is what the trials actually found, and what I think is reasonable to do with that.
What creatine is, briefly
Creatine is a compound your body already makes, stored mostly in muscle, where it helps regenerate energy during short bursts of effort. You also get some from meat and fish. Supplementing raises how much your muscles have on hand, which is why it has been studied in athletes for decades.
That long history matters for one reason above all: it means we have unusually good safety data for a supplement.
Does creatine help maintain muscle and strength?
This is the part the evidence supports.
A 2026 systematic review and meta-analysis in the Journal of the International Society of Sports Nutrition pooled seven randomized controlled trials covering 608 postmenopausal women. Compared with placebo, creatine produced a small gain in lean mass — about 0.37 kg — and a more noticeable improvement in leg-press strength, around 7.5 kg. Both results were statistically significant. Benefits showed up mainly at doses of 5 g per day or more, taken alongside resistance training.
Those are real effects, and in a life stage where muscle mass and strength tend to decline, preserving either is worth something. They are also modest. A third of a kilogram of lean mass is not a transformation, and it is worth being honest about that rather than rounding it up.
The pattern across every trial is the same: creatine works as an addition to resistance training, not as a substitute for it.
Does creatine protect bone?
This is where the marketing has run well ahead of the research.
Two long trials have tested it directly, and both are worth knowing about.
In the first, 200 postmenopausal women with osteopenia took 3 g of creatine daily for two years, without a structured exercise program. Bone density declined at the lumbar spine, femoral neck, and total femur — and declined the same amount in both groups. Creatine changed nothing. It also did not affect lean mass or muscle function. The authors concluded that the results refute the long-standing notion that creatine alone has bone-building or anabolic properties over the long run.
The second trial paired creatine with exercise: 237 postmenopausal women took a weight-based dose alongside resistance training and walking, again for two years. Bone mineral density still did not improve compared with placebo. There were some favourable changes in bone geometry at the femoral neck — measures that relate to structural strength rather than density — and the creatine group gained lean mass and walked faster. But the primary bone outcome was negative, and the researchers said plainly that creatine has a very minimal effect, if any, on bone mineral density in postmenopausal women.
The 2026 meta-analysis reached the same conclusion: no overall change in bone density.
So creatine is not a bone treatment. If bone loss is your concern, the interventions with real evidence behind them are resistance and impact training, adequate protein, vitamin D and calcium sufficiency, and — where appropriate — medication. Creatine may belong in that picture, but not as the centrepiece.
What about brain fog, mood, and memory?
This is the claim I would hold most loosely.
A systematic review of creatine and cognition found that creatine does cross the blood-brain barrier, but inefficiently — the brain relies mostly on making its own. Across fifteen studies, creatine showed no meaningful cognitive benefit in healthy people under ordinary conditions. There were weak and inconsistent signals in people under some form of physiological stress: sleep deprivation, low dietary intake, older age.
That is not nothing, and it is an interesting area. But "creatine for brain fog" is currently a hypothesis being marketed as a finding.
If brain fog is what actually brought you here, it usually deserves a proper look rather than a supplement. Thyroid function, iron stores, sleep quality, blood sugar patterns, and perimenopausal hormone shifts all produce it, and they are distinguishable from one another. I have written separately about what a TSH alone can and can't tell you, ferritin in women, and how short sleep changes blood sugar — any of those can be the answer, and none of them respond to creatine.
An honest caveat about who was studied
Almost all of this research was done in postmenopausal women, with an average age around 62. The current conversation is aimed at women in their forties, in perimenopause.
That is not the same population. It is reasonable to expect the findings to carry over, and there is no particular reason to think creatine behaves differently at 45 than at 62 — but it has not really been tested there. Anyone telling you the perimenopause data is settled is describing studies that have not been done yet.
Is it safe?
Better established than most supplements.
In the 2026 meta-analysis, side effects occurred at the same rate as placebo, and kidney function was unchanged. Decades of athletic research point the same direction in healthy people. If you have kidney disease or reduced kidney function, that is a genuine reason to check first rather than assume.
Two things worth clearing up:
Hair loss. This traces back to a single three-week study in college rugby players that measured DHT — a hormone associated with pattern hair loss — not hair loss itself. No study since has replicated the hormonal finding, and none has shown increased hair loss. One unreplicated surrogate marker is a thin foundation for a widely repeated warning.
Water weight. Creatine draws a small amount of water into muscle. Some women notice a pound or two early on. It is intracellular, not bloating, and it is not fat gain.
If you decide to try it
| Question | What the trials used |
|---|---|
| Which form | Creatine monohydrate — the form nearly every study tested |
| How much | 3–5 g daily; benefits clustered at 5 g and above |
| Loading phase | Not required; it only fills muscle stores faster |
| When | Timing does not appear to matter — daily consistency does |
| With what | Resistance training, in every trial that showed benefit |
Third-party testing is worth looking for, since supplements are not reviewed for content before sale.
And the honest framing: creatine is a reasonable, low-risk, inexpensive addition if you are strength training. Without that, the two-year trial tells you what to expect, which is very little. The training is doing most of the work. Creatine makes it slightly more productive.
Where this fits
Supplements are tools. They are useful when they address something real, and they are a distraction when they stand in for a question that hasn't been asked yet.
If you are in perimenopause and feeling the shifts — the fatigue, the changes in strength and recovery, the sleep that isn't what it was — creatine is a small piece at most. What usually helps more is understanding which of those changes are hormonal, which are thyroid or iron or sleep, and which are simply the result of losing muscle slowly over a decade. Those have different answers.
If you would like help sorting out which is which, that is the kind of question a functional medicine evaluation is built for, and it is also something I work through with patients in ongoing primary care.
Natalie Ball is a board-certified family nurse practitioner and the founder of Encompass Care, an integrative primary care and functional medicine practice licensed in Colorado and Connecticut. She holds degrees from the University of Pennsylvania and Harvard University.
More articles by Natalie →This article is for general education and isn't medical advice for your particular situation. Talk with your own clinician before making changes to your care.
